Literature DB >> 19749199

Guidelines for the diagnosis and treatment of pulmonary hypertension.

N Galiè, M M Hoeper, M Humbert, A Torbicki, J-L Vachiery, J A Barbera, M Beghetti, P Corris, S Gaine, J S Gibbs, M A Gomez-Sanchez, G Jondeau, W Klepetko, C Opitz, A Peacock, L Rubin, M Zellweger, G Simonneau.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19749199     DOI： 10.1183/09031936.00139009

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  302 in total

1.  Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension.

Authors:  Athénaïs Boucly; Jason Weatherald; Laurent Savale; Xavier Jaïs; Vincent Cottin; Grégoire Prevot; François Picard; Pascal de Groote; Mitja Jevnikar; Emmanuel Bergot; Ari Chaouat; Céline Chabanne; Arnaud Bourdin; Florence Parent; David Montani; Gérald Simonneau; Marc Humbert; Olivier Sitbon
Journal:  Eur Respir J       Date:  2017-08-03       Impact factor: 16.671

2.  Experimentation with aerosol bonsetan, pirfenidone, treprostinil and sidenafil.

Authors:  Haidong Huang; Paul Zarogoulidis; Sofia Lampaki; John Organtzis; Dimitris Petridis; Konstantinos Porpodis; Antonis Papaiwannou; Vasilis Karageorgiou; Georgia Pitsiou; Ioannis Kioumis; Wolfgang Hohenforst-Schmidt; Qiang Li; Kaid Darwiche; Lutz Freitag; Aggeliki Rapti; Konstantinos Zarogoulidis
Journal:  J Thorac Dis       Date:  2014-10       Impact factor: 2.895

3.  [Histopathological aspects of pulmonary hypertension].

Authors:  D Jonigk; M M Hoeper; H Kreipe; F Länger
Journal:  Pathologe       Date:  2012-05       Impact factor: 1.011

Review 4.  Today's and tomorrow's imaging and circulating biomarkers for pulmonary arterial hypertension.

Authors:  Marjorie Barrier; Jolyane Meloche; Maria Helena Jacob; Audrey Courboulin; Steeve Provencher; Sébastien Bonnet
Journal:  Cell Mol Life Sci       Date:  2012-03-25       Impact factor: 9.261

5.  Vascular compromise and hemodynamics in pulmonary arterial hypertension: model predictions.

Authors:  Zoheir Bshouty
Journal:  Can Respir J       Date:  2012 May-Jun       Impact factor: 2.409

Review 6.  Pathobiology of pulmonary arterial hypertension and right ventricular failure.

Authors:  Norbert F Voelkel; Jose Gomez-Arroyo; Antonio Abbate; Harm J Bogaard; Mark R Nicolls
Journal:  Eur Respir J       Date:  2012-06-27       Impact factor: 16.671

Review 7.  Update on pulmonary hypertension 2009.

Authors:  Mark T Gladwin; Hossein-Ardeschir Ghofrani
Journal:  Am J Respir Crit Care Med       Date:  2010-05-15       Impact factor: 21.405

8.  Safety, tolerability and pharmacokinetics of an intravenous bolus of sildenafil in patients with pulmonary arterial hypertension.

Authors:  Jean-Luc Vachiery; Sandrine Huez; Hunter Gillies; Gary Layton; Naoto Hayashi; Xiang Gao; Robert Naeije
Journal:  Br J Clin Pharmacol       Date:  2011-02       Impact factor: 4.335

9.  Recommendations for screening and detection of connective tissue disease-associated pulmonary arterial hypertension.

Authors:  Dinesh Khanna; Heather Gladue; Richard Channick; Lorinda Chung; Oliver Distler; Daniel E Furst; Eric Hachulla; Marc Humbert; David Langleben; Stephen C Mathai; Rajeev Saggar; Scott Visovatti; Nezam Altorok; Whitney Townsend; John FitzGerald; Vallerie V McLaughlin
Journal:  Arthritis Rheum       Date:  2013-12

10.  Promising therapeutic effects of sodium tanshinone IIA sulfonate towards pulmonary arterial hypertension in patients.

Authors:  Jian Wang; Wenju Lu; Wei Wang; Nuofu Zhang; Hua Wu; Chunli Liu; Xiuqing Chen; Yonghua Chen; Yuqin Chen; Qian Jiang; Lei Xu; Lichun Tian; Pixin Ran; Nanshan Zhong
Journal:  J Thorac Dis       Date:  2013-04       Impact factor: 2.895
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.